Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosaAlonso Sánchez-Cruz, Catalina Hernández‐Sánchez, Carmen Gil et al.|Molecular Neurodegeneration|2018Cited by 42
Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosaMiguel Marchena, Enrique J. de la Rosa, Beatriz Villarejo‐Zori et al.|Journal of Enzyme Inhibition and Medicinal Chemistry|2017Cited by 25